Compare PBFS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBFS | QTRX |
|---|---|---|
| Founded | 1889 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.8M | 306.0M |
| IPO Year | 2019 | 2017 |
| Metric | PBFS | QTRX |
|---|---|---|
| Price | $13.92 | $3.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 7.7K | ★ 950.3K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.07 | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | $15,814,000.00 | ★ $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | N/A | $10.04 |
| P/E Ratio | $17.15 | ★ N/A |
| Revenue Growth | 5.76 | ★ 64.52 |
| 52 Week Low | $10.86 | $3.16 |
| 52 Week High | $15.18 | $8.77 |
| Indicator | PBFS | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.11 | 31.17 |
| Support Level | $12.89 | N/A |
| Resistance Level | $14.73 | $3.90 |
| Average True Range (ATR) | 0.35 | 0.24 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 43.14 | 12.21 |
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.